http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-417158-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_137062e532b03cac4f3601a124278302 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D215-18 |
| filingDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c7d92af1c3da9eae79ace88376a0e69a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccd147009d30314b84db9284016d7e95 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_334769c20fa8a415735b6a5d20608d76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dda7a8a8d297cb217dd608ed96343dac |
| publicationDate | 2017-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | PL-417158-A1 |
| titleOfInvention | Acetylene sulfamoylquinoline derivatives with anti-cancer effect, method of their preparation and pharmaceutical composition containing them |
| abstract | The subject of the present application are quinoline derivatives with antitumor activity of the general formula 1, containing an acetylene and sulfamoyl moiety. In addition, the subject of the application is also a process for the preparation of acetylene sulfamoylquinoline derivatives of general formula 1 and a pharmaceutical composition, comprising an active substance and pharmaceutically acceptable carriers and / or excipients, characterized in that as active substance contains at least one compound of general formula 1, defined in claim 1 and / or a pharmacologically acceptable salt thereof. |
| priorityDate | 2016-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 20.